1548

COM:GENSCRIPT

GenScript Biotech Corporation

  • Stock

HKD

Last Close

10.18

25/11 08:08

Market Cap

20.17B

Beta: -

Volume Today

7.76M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
1.90M
-
3.13M
64.70%
5.56M
77.50%
9.65M
73.70%
16.14M
67.21%
25.80M
59.83%
38.05M
47.49%
52.15M
37.04%
56.64M
8.62%
average payables
2.64M
-
3.38M
28.07%
6.25M
84.84%
9.67M
54.65%
14.41M
48.98%
20.50M
42.30%
26.78M
30.61%
42.97M
60.46%
47.86M
11.38%
average receivables
160.86M
-
book value per share
0.04
-
0.13
224.46%
0.11
14.88%
0.13
19.26%
0.27
110.20%
0.21
22.68%
0.47
129.75%
0.43
8.67%
0.48
11.22%
0.66
36.97%
capex per share
-0.00
-
-0.01
32.76%
-0.01
13.63%
-0.02
246.20%
-0.04
138.17%
-0.06
43.95%
-0.07
5.11%
-0.07
0.68%
-0.10
43.46%
-0.12
25.37%
capex to depreciation
-1.87
-
-1.53
18.12%
-1.48
3.34%
-1.67
12.39%
-4.57
174.11%
-6.16
34.76%
-5.74
6.70%
-3.88
32.37%
-2.88
25.95%
-3.17
10.18%
-3.46
9.33%
capex to operating cash flow
-0.70
-
-0.62
12.03%
-0.38
38.49%
-0.27
28.75%
-1.50
454.35%
-0.27
81.99%
3.96
1,568.41%
0.85
78.63%
1.00
18.80%
1.69
68.48%
0.89
47.17%
capex to revenue
-0.14
-
-0.11
23.32%
-0.09
20.13%
-0.08
8.75%
-0.21
167.57%
-0.34
64.53%
-0.43
25.84%
-0.33
24.63%
-0.27
17.75%
-0.33
21.02%
-0.31
6.09%
cash per share
0.02
-
0.09
394.11%
0.08
5.89%
0.07
9.53%
0.32
325.42%
0.23
26.97%
0.41
76.35%
0.69
70.33%
0.70
0.98%
0.86
23.91%
days of inventory on hand
23.33
-
25.05
7.38%
24.94
0.41%
40.16
61.01%
52.24
30.07%
62.59
19.82%
77.87
24.41%
85.86
10.26%
78.00
9.16%
68.02
12.79%
45.28
33.42%
days payables outstanding
30.70
-
40.44
31.71%
29.74
26.47%
41.25
38.73%
61.93
50.12%
56.34
9.03%
69.13
22.71%
63.22
8.55%
53.06
16.07%
63.28
19.25%
33.92
46.39%
days sales outstanding
54.72
-
94.54
-
debt to assets
-0.01
-
-0.01
44.91%
-0.26
4,432.91%
0.03
110.46%
0.04
40.05%
0.07
84.39%
0.14
96.05%
0.25
79.15%
debt to equity
-0.01
-
-0.01
0.22%
-0.50
3,650.79%
0.06
112.68%
0.06
3.24%
0.18
191.54%
0.35
94.65%
0.60
73.13%
dividend yield
0.00
-
0.01
-
0.07
1,097.75%
earnings yield
0.02
-
0.09
280.05%
0.03
61.82%
0.01
82.89%
0.01
55.96%
-0.03
417.64%
-0.10
266.05%
-0.06
45.40%
-0.06
14.97%
-0.02
70.98%
enterprise value
-22.46M
-
246.66M
1,198.38%
99.38M
59.71%
658.76M
562.87%
4.51B
585.33%
1.93B
57.22%
3.98B
106.26%
2.18B
45.24%
7.96B
264.86%
6.00B
24.60%
4.52B
24.71%
enterprise value over ebitda
-1.72
-
18.76
1,193.03%
5.10
72.82%
17.38
240.85%
101.54
484.31%
54.61
46.22%
-43.56
179.77%
-12.56
71.17%
-17.72
41.10%
-16.14
8.89%
-12.68
21.44%
ev to operating cash flow
-1.87
-
20.21
1,182.00%
5.06
74.96%
19.80
291.17%
211.28
967.22%
6.54
96.91%
-132.99
2,134.14%
-14.44
89.14%
-58.19
303.01%
-49.89
14.26%
-15.75
68.43%
ev to sales
-0.37
-
3.52
1,043.18%
1.15
67.48%
5.74
400.95%
29.58
415.11%
8.36
71.73%
14.57
74.32%
5.58
61.70%
15.57
179.04%
9.59
38.42%
5.38
43.89%
free cash flow per share
0.00
-
0.01
249.02%
0.01
42.46%
-0.01
142.45%
0.12
2,046.74%
-0.08
166.52%
-0.15
83.15%
-0.14
7.95%
-0.15
14.37%
-0.26
66.95%
free cash flow yield
0.02
-
0.06
248.78%
0.03
49.13%
-0.00
107.48%
0.09
4,008.47%
-0.04
139.46%
-0.10
187.03%
-0.03
69.84%
-0.05
58.96%
-0.11
118.29%
graham net net
-0.00
-
0.06
6,200.16%
0.06
3.94%
-0.08
246.59%
0.08
196.69%
-0.04
152.99%
0.08
287.70%
0.14
72.21%
0.15
4.97%
0.32
115.08%
graham number
0.06
-
0.20
251.28%
0.19
4.59%
0.21
7.60%
0.27
27.78%
0.54
103.48%
1.26
131.65%
1.55
23.36%
1.49
4.08%
0.82
44.86%
income quality
2.00
-
1.56
22.27%
0.85
45.13%
1.02
19.77%
0.55
45.81%
13.01
2,246.04%
0.26
97.98%
0.54
103.42%
0.28
48.58%
0.28
1.12%
3.01
978.41%
intangibles to total assets
0.00
-
0.00
19.97%
0.00
30.99%
0.02
214.16%
0.01
49.78%
0.04
387.89%
0.07
90.82%
0.04
38.47%
0.03
34.23%
0.01
64.81%
0.01
42.95%
interest coverage
20.07
-
-1.70
108.49%
3.25K
191,044.67%
-212.86
106.55%
431.42
302.68%
-143.53
133.27%
-145.72
1.53%
-209.02
43.43%
-32.86
84.28%
interest debt per share
0.00
-
-0.01
2,874.72%
-0.00
80.32%
-0.00
27.36%
-0.13
7,329.51%
0.01
110.12%
0.03
120.88%
0.08
163.51%
0.17
121.34%
0.40
128.46%
inventory turnover
15.65
-
14.57
6.87%
14.63
0.41%
9.09
37.89%
6.99
23.12%
5.83
16.54%
4.69
19.62%
4.25
9.30%
4.68
10.08%
5.37
14.67%
8.06
50.21%
invested capital
-0.01
-
-0.01
0.22%
-0.50
3,650.79%
0.06
112.68%
0.06
3.24%
0.18
191.54%
0.35
94.65%
0.60
73.13%
market cap
272.30M
-
203.10M
25.41%
795.22M
291.54%
4.64B
483.30%
2.42B
47.93%
4.21B
74.38%
2.76B
34.58%
8.98B
226.03%
6.68B
25.69%
5.13B
23.13%
net current asset value
7.29M
-
13.16M
80.53%
100.19M
661.36%
121.90M
21.67%
121.95M
0.04%
255.79M
109.75%
36.93M
85.56%
361.36M
878.42%
498.15M
37.85%
581.24M
16.68%
1.01B
73.80%
net debt to ebitda
-1.72
-
-1.95
13.60%
-5.32
172.88%
-3.60
32.35%
-2.79
22.62%
-13.69
391.32%
2.50
118.24%
3.30
32.38%
2.28
30.98%
1.81
20.48%
1.72
5.17%
net income per share
0.00
-
0.01
280.31%
0.02
6.94%
0.02
2.92%
0.01
22.32%
-0.06
635.50%
-0.15
133.57%
-0.25
66.63%
-0.20
17.28%
-0.05
77.80%
operating cash flow per share
0.01
-
0.02
115.84%
0.02
21.21%
0.01
37.55%
0.16
1,222.34%
-0.02
109.80%
-0.08
391.97%
-0.07
15.25%
-0.06
14.85%
-0.14
137.32%
payables turnover
11.89
-
9.03
24.08%
12.27
35.99%
8.85
27.92%
5.89
33.39%
6.48
9.93%
5.28
18.51%
5.77
9.35%
6.88
19.15%
5.77
16.14%
10.76
86.54%
receivables turnover
6.67
-
3.86
-
research and ddevelopement to revenue
0.10
-
0.32
-
0.68
112.23%
0.67
0.97%
0.70
4.06%
0.62
11.10%
0.52
17.31%
return on tangible assets
0.07
-
0.07
6.54%
0.10
43.99%
0.12
21.73%
0.05
55.61%
0.02
53.93%
-0.14
692.37%
-0.20
42.85%
-0.23
13.57%
-0.17
26.53%
-0.03
83.30%
revenue per share
0.04
-
0.07
66.21%
0.07
5.35%
0.09
29.39%
0.13
44.75%
0.15
14.40%
0.21
39.46%
0.25
22.40%
0.30
18.55%
0.40
33.50%
roe
0.11
-
0.10
12.40%
0.12
17.21%
0.15
25.63%
0.12
18.60%
0.04
63.04%
-0.31
792.61%
-0.31
1.67%
-0.57
82.45%
-0.42
25.63%
-0.07
83.79%
roic
0.13
-
0.11
19.19%
0.07
29.83%
0.15
104.95%
0.12
19.31%
0.09
30.25%
-0.28
429.70%
-0.21
24.00%
-0.47
119.28%
-0.31
34.79%
-0.19
38.08%
sales general and administrative to revenue
0.27
-
0.31
12.45%
0.33
7.41%
0.27
19.41%
0.26
0.96%
0.18
33.12%
0.20
15.07%
0.23
14.35%
0.26
13.87%
0.29
10.80%
0.25
12.82%
shareholders equity per share
0.04
-
0.13
224.46%
0.11
14.88%
0.13
19.26%
0.27
110.20%
0.21
22.68%
0.47
129.75%
0.43
8.67%
0.48
11.22%
0.66
36.97%
stock based compensation to revenue
0.01
-
0.05
576.25%
0.04
17.70%
0.02
58.56%
0.02
15.08%
0.04
108.08%
0.04
2.94%
0.05
14.41%
0.08
72.11%
0.10
34.08%
0.08
27.41%
tangible asset value
52.30M
-
61.40M
17.40%
148.35M
141.62%
180.51M
21.68%
224.38M
24.31%
458.37M
104.28%
307.65M
32.88%
750.86M
144.06%
1.03B
36.81%
1.34B
30.08%
2.02B
51.49%
tangible book value per share
0.04
-
0.12
224.17%
0.11
12.97%
0.13
20.89%
0.26
95.39%
0.17
35.11%
0.40
138.05%
0.51
28.07%
0.64
25.96%
0.96
50.73%
working capital
8.68M
-
14.60M
68.33%
102.12M
599.26%
124.69M
22.11%
125.18M
0.39%
525.95M
320.16%
329.54M
37.34%
665.26M
101.88%
1.17B
76.41%
1.22B
3.87%
1.86B
52.45%

All numbers in HKD (except ratios and percentages)